Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Tenofovir Disoproxil Fumarate Market Growth 2022-2028

  • LP 4768437
  • 114 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tenofovir Disoproxil Fumarate will have significant change from previous year. According to our (LP Information) latest study, the global Tenofovir Disoproxil Fumarate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tenofovir Disoproxil Fumarate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Tenofovir Disoproxil Fumarate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tenofovir Disoproxil Fumarate market, reaching US$ million by the year 2028. As for the Europe Tenofovir Disoproxil Fumarate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tenofovir Disoproxil Fumarate players cover Glaxo SmithKline, Gilead PHARMACARE, Chengdu Brilliant Pharmaceutical, and CHIA TAI TIANQING (CTTQ) Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tenofovir Disoproxil Fumarate market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

30 Pcs/Box

10 Pcs/Box

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

HIV-1 Infection

Chronic Hepatitis

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Glaxo SmithKline

Gilead PHARMACARE

Chengdu Brilliant Pharmaceutical

CHIA TAI TIANQING (CTTQ) Pharmaceutical

Anhui Biochem Pharmaceutical

Qilu Pharmaceutical

Cipla

Zydus Cadila

Dr Reddy's Laboratories

Mylan Pharmaceuticals

Natco Pharma

Emcure Pharmaceuticals

Torrent Pharmaceuticals

Wockhardt Ltd

Hetero Drugs

Abbott

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tenofovir Disoproxil Fumarate Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tenofovir Disoproxil Fumarate by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tenofovir Disoproxil Fumarate by Country/Region, 2017, 2022 & 2028

2.2 Tenofovir Disoproxil Fumarate Segment by Type

2.2.1 30 Pcs/Box

2.2.2 10 Pcs/Box

2.3 Tenofovir Disoproxil Fumarate Sales by Type

2.3.1 Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

2.3.2 Global Tenofovir Disoproxil Fumarate Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tenofovir Disoproxil Fumarate Sale Price by Type (2017-2022)

2.4 Tenofovir Disoproxil Fumarate Segment by Application

2.4.1 HIV-1 Infection

2.4.2 Chronic Hepatitis

2.4.3 Other

2.5 Tenofovir Disoproxil Fumarate Sales by Application

2.5.1 Global Tenofovir Disoproxil Fumarate Sale Market Share by Application (2017-2022)

2.5.2 Global Tenofovir Disoproxil Fumarate Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tenofovir Disoproxil Fumarate Sale Price by Application (2017-2022)

3 Global Tenofovir Disoproxil Fumarate by Company

3.1 Global Tenofovir Disoproxil Fumarate Breakdown Data by Company

3.1.1 Global Tenofovir Disoproxil Fumarate Annual Sales by Company (2020-2022)

3.1.2 Global Tenofovir Disoproxil Fumarate Sales Market Share by Company (2020-2022)

3.2 Global Tenofovir Disoproxil Fumarate Annual Revenue by Company (2020-2022)

3.2.1 Global Tenofovir Disoproxil Fumarate Revenue by Company (2020-2022)

3.2.2 Global Tenofovir Disoproxil Fumarate Revenue Market Share by Company (2020-2022)

3.3 Global Tenofovir Disoproxil Fumarate Sale Price by Company

3.4 Key Manufacturers Tenofovir Disoproxil Fumarate Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tenofovir Disoproxil Fumarate Product Location Distribution

3.4.2 Players Tenofovir Disoproxil Fumarate Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tenofovir Disoproxil Fumarate by Geographic Region

4.1 World Historic Tenofovir Disoproxil Fumarate Market Size by Geographic Region (2017-2022)

4.1.1 Global Tenofovir Disoproxil Fumarate Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tenofovir Disoproxil Fumarate Annual Revenue by Geographic Region

4.2 World Historic Tenofovir Disoproxil Fumarate Market Size by Country/Region (2017-2022)

4.2.1 Global Tenofovir Disoproxil Fumarate Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tenofovir Disoproxil Fumarate Annual Revenue by Country/Region

4.3 Americas Tenofovir Disoproxil Fumarate Sales Growth

4.4 APAC Tenofovir Disoproxil Fumarate Sales Growth

4.5 Europe Tenofovir Disoproxil Fumarate Sales Growth

4.6 Middle East & Africa Tenofovir Disoproxil Fumarate Sales Growth

5 Americas

5.1 Americas Tenofovir Disoproxil Fumarate Sales by Country

5.1.1 Americas Tenofovir Disoproxil Fumarate Sales by Country (2017-2022)

5.1.2 Americas Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022)

5.2 Americas Tenofovir Disoproxil Fumarate Sales by Type

5.3 Americas Tenofovir Disoproxil Fumarate Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tenofovir Disoproxil Fumarate Sales by Region

6.1.1 APAC Tenofovir Disoproxil Fumarate Sales by Region (2017-2022)

6.1.2 APAC Tenofovir Disoproxil Fumarate Revenue by Region (2017-2022)

6.2 APAC Tenofovir Disoproxil Fumarate Sales by Type

6.3 APAC Tenofovir Disoproxil Fumarate Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tenofovir Disoproxil Fumarate by Country

7.1.1 Europe Tenofovir Disoproxil Fumarate Sales by Country (2017-2022)

7.1.2 Europe Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022)

7.2 Europe Tenofovir Disoproxil Fumarate Sales by Type

7.3 Europe Tenofovir Disoproxil Fumarate Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tenofovir Disoproxil Fumarate by Country

8.1.1 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022)

8.2 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type

8.3 Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tenofovir Disoproxil Fumarate

10.3 Manufacturing Process Analysis of Tenofovir Disoproxil Fumarate

10.4 Industry Chain Structure of Tenofovir Disoproxil Fumarate

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tenofovir Disoproxil Fumarate Distributors

11.3 Tenofovir Disoproxil Fumarate Customer

12 World Forecast Review for Tenofovir Disoproxil Fumarate by Geographic Region

12.1 Global Tenofovir Disoproxil Fumarate Market Size Forecast by Region

12.1.1 Global Tenofovir Disoproxil Fumarate Forecast by Region (2023-2028)

12.1.2 Global Tenofovir Disoproxil Fumarate Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tenofovir Disoproxil Fumarate Forecast by Type

12.7 Global Tenofovir Disoproxil Fumarate Forecast by Application

13 Key Players Analysis

13.1 Glaxo SmithKline

13.1.1 Glaxo SmithKline Company Information

13.1.2 Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Offered

13.1.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Glaxo SmithKline Main Business Overview

13.1.5 Glaxo SmithKline Latest Developments

13.2 Gilead PHARMACARE

13.2.1 Gilead PHARMACARE Company Information

13.2.2 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Offered

13.2.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Gilead PHARMACARE Main Business Overview

13.2.5 Gilead PHARMACARE Latest Developments

13.3 Chengdu Brilliant Pharmaceutical

13.3.1 Chengdu Brilliant Pharmaceutical Company Information

13.3.2 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

13.3.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Chengdu Brilliant Pharmaceutical Main Business Overview

13.3.5 Chengdu Brilliant Pharmaceutical Latest Developments

13.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical

13.4.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information

13.4.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

13.4.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Main Business Overview

13.4.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Latest Developments

13.5 Anhui Biochem Pharmaceutical

13.5.1 Anhui Biochem Pharmaceutical Company Information

13.5.2 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

13.5.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Anhui Biochem Pharmaceutical Main Business Overview

13.5.5 Anhui Biochem Pharmaceutical Latest Developments

13.6 Qilu Pharmaceutical

13.6.1 Qilu Pharmaceutical Company Information

13.6.2 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

13.6.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Qilu Pharmaceutical Main Business Overview

13.6.5 Qilu Pharmaceutical Latest Developments

13.7 Cipla

13.7.1 Cipla Company Information

13.7.2 Cipla Tenofovir Disoproxil Fumarate Product Offered

13.7.3 Cipla Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cipla Main Business Overview

13.7.5 Cipla Latest Developments

13.8 Zydus Cadila

13.8.1 Zydus Cadila Company Information

13.8.2 Zydus Cadila Tenofovir Disoproxil Fumarate Product Offered

13.8.3 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zydus Cadila Main Business Overview

13.8.5 Zydus Cadila Latest Developments

13.9 Dr Reddy's Laboratories

13.9.1 Dr Reddy's Laboratories Company Information

13.9.2 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Offered

13.9.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Dr Reddy's Laboratories Main Business Overview

13.9.5 Dr Reddy's Laboratories Latest Developments

13.10 Mylan Pharmaceuticals

13.10.1 Mylan Pharmaceuticals Company Information

13.10.2 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

13.10.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mylan Pharmaceuticals Main Business Overview

13.10.5 Mylan Pharmaceuticals Latest Developments

13.11 Natco Pharma

13.11.1 Natco Pharma Company Information

13.11.2 Natco Pharma Tenofovir Disoproxil Fumarate Product Offered

13.11.3 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Natco Pharma Main Business Overview

13.11.5 Natco Pharma Latest Developments

13.12 Emcure Pharmaceuticals

13.12.1 Emcure Pharmaceuticals Company Information

13.12.2 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

13.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Emcure Pharmaceuticals Main Business Overview

13.12.5 Emcure Pharmaceuticals Latest Developments

13.13 Torrent Pharmaceuticals

13.13.1 Torrent Pharmaceuticals Company Information

13.13.2 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

13.13.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Torrent Pharmaceuticals Main Business Overview

13.13.5 Torrent Pharmaceuticals Latest Developments

13.14 Wockhardt Ltd

13.14.1 Wockhardt Ltd Company Information

13.14.2 Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Offered

13.14.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wockhardt Ltd Main Business Overview

13.14.5 Wockhardt Ltd Latest Developments

13.15 Hetero Drugs

13.15.1 Hetero Drugs Company Information

13.15.2 Hetero Drugs Tenofovir Disoproxil Fumarate Product Offered

13.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hetero Drugs Main Business Overview

13.15.5 Hetero Drugs Latest Developments

13.16 Abbott

13.16.1 Abbott Company Information

13.16.2 Abbott Tenofovir Disoproxil Fumarate Product Offered

13.16.3 Abbott Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Abbott Main Business Overview

13.16.5 Abbott Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Tenofovir Disoproxil Fumarate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tenofovir Disoproxil Fumarate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 30 Pcs/Box

Table 4. Major Players of 10 Pcs/Box

Table 5. Global Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

Table 7. Global Tenofovir Disoproxil Fumarate Revenue by Type (2017-2022) & ($ million)

Table 8. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2017-2022)

Table 9. Global Tenofovir Disoproxil Fumarate Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Table 12. Global Tenofovir Disoproxil Fumarate Revenue by Application (2017-2022)

Table 13. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2017-2022)

Table 14. Global Tenofovir Disoproxil Fumarate Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Tenofovir Disoproxil Fumarate Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Tenofovir Disoproxil Fumarate Sales Market Share by Company (2020-2022)

Table 17. Global Tenofovir Disoproxil Fumarate Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Company (2020-2022)

Table 19. Global Tenofovir Disoproxil Fumarate Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Tenofovir Disoproxil Fumarate Producing Area Distribution and Sales Area

Table 21. Players Tenofovir Disoproxil Fumarate Products Offered

Table 22. Tenofovir Disoproxil Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Tenofovir Disoproxil Fumarate Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Tenofovir Disoproxil Fumarate Sales Market Share Geographic Region (2017-2022)

Table 27. Global Tenofovir Disoproxil Fumarate Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Tenofovir Disoproxil Fumarate Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Tenofovir Disoproxil Fumarate Sales Market Share by Country/Region (2017-2022)

Table 31. Global Tenofovir Disoproxil Fumarate Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2022)

Table 35. Americas Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2022)

Table 37. Americas Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

Table 39. Americas Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Table 41. APAC Tenofovir Disoproxil Fumarate Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2022)

Table 43. APAC Tenofovir Disoproxil Fumarate Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2017-2022)

Table 45. APAC Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

Table 47. APAC Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Table 49. Europe Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2022)

Table 51. Europe Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2022)

Table 53. Europe Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

Table 55. Europe Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Tenofovir Disoproxil Fumarate Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Tenofovir Disoproxil Fumarate

Table 66. Key Market Challenges & Risks of Tenofovir Disoproxil Fumarate

Table 67. Key Industry Trends of Tenofovir Disoproxil Fumarate

Table 68. Tenofovir Disoproxil Fumarate Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Tenofovir Disoproxil Fumarate Distributors List

Table 71. Tenofovir Disoproxil Fumarate Customer List

Table 72. Global Tenofovir Disoproxil Fumarate Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Tenofovir Disoproxil Fumarate Sales Market Forecast by Region

Table 74. Global Tenofovir Disoproxil Fumarate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Tenofovir Disoproxil Fumarate Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Tenofovir Disoproxil Fumarate Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Tenofovir Disoproxil Fumarate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Tenofovir Disoproxil Fumarate Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Tenofovir Disoproxil Fumarate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Tenofovir Disoproxil Fumarate Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Tenofovir Disoproxil Fumarate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Tenofovir Disoproxil Fumarate Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Tenofovir Disoproxil Fumarate Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Tenofovir Disoproxil Fumarate Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Tenofovir Disoproxil Fumarate Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Tenofovir Disoproxil Fumarate Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Tenofovir Disoproxil Fumarate Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Tenofovir Disoproxil Fumarate Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Tenofovir Disoproxil Fumarate Revenue Market Share Forecast by Application (2023-2028)

Table 92. Glaxo SmithKline Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 93. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Offered

Table 94. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Glaxo SmithKline Main Business

Table 96. Glaxo SmithKline Latest Developments

Table 97. Gilead PHARMACARE Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 98. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Offered

Table 99. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Gilead PHARMACARE Main Business

Table 101. Gilead PHARMACARE Latest Developments

Table 102. Chengdu Brilliant Pharmaceutical Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 103. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

Table 104. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Chengdu Brilliant Pharmaceutical Main Business

Table 106. Chengdu Brilliant Pharmaceutical Latest Developments

Table 107. CHIA TAI TIANQING (CTTQ) Pharmaceutical Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 108. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

Table 109. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. CHIA TAI TIANQING (CTTQ) Pharmaceutical Main Business

Table 111. CHIA TAI TIANQING (CTTQ) Pharmaceutical Latest Developments

Table 112. Anhui Biochem Pharmaceutical Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 113. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

Table 114. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Anhui Biochem Pharmaceutical Main Business

Table 116. Anhui Biochem Pharmaceutical Latest Developments

Table 117. Qilu Pharmaceutical Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 118. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Offered

Table 119. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Qilu Pharmaceutical Main Business

Table 121. Qilu Pharmaceutical Latest Developments

Table 122. Cipla Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 123. Cipla Tenofovir Disoproxil Fumarate Product Offered

Table 124. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Cipla Main Business

Table 126. Cipla Latest Developments

Table 127. Zydus Cadila Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 128. Zydus Cadila Tenofovir Disoproxil Fumarate Product Offered

Table 129. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Zydus Cadila Main Business

Table 131. Zydus Cadila Latest Developments

Table 132. Dr Reddy's Laboratories Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 133. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Offered

Table 134. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Dr Reddy's Laboratories Main Business

Table 136. Dr Reddy's Laboratories Latest Developments

Table 137. Mylan Pharmaceuticals Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 138. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

Table 139. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Mylan Pharmaceuticals Main Business

Table 141. Mylan Pharmaceuticals Latest Developments

Table 142. Natco Pharma Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 143. Natco Pharma Tenofovir Disoproxil Fumarate Product Offered

Table 144. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Natco Pharma Main Business

Table 146. Natco Pharma Latest Developments

Table 147. Emcure Pharmaceuticals Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 148. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

Table 149. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Emcure Pharmaceuticals Main Business

Table 151. Emcure Pharmaceuticals Latest Developments

Table 152. Torrent Pharmaceuticals Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 153. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Offered

Table 154. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Torrent Pharmaceuticals Main Business

Table 156. Torrent Pharmaceuticals Latest Developments

Table 157. Wockhardt Ltd Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 158. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Offered

Table 159. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Wockhardt Ltd Main Business

Table 161. Wockhardt Ltd Latest Developments

Table 162. Hetero Drugs Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 163. Hetero Drugs Tenofovir Disoproxil Fumarate Product Offered

Table 164. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Hetero Drugs Main Business

Table 166. Hetero Drugs Latest Developments

Table 167. Abbott Basic Information, Tenofovir Disoproxil Fumarate Manufacturing Base, Sales Area and Its Competitors

Table 168. Abbott Tenofovir Disoproxil Fumarate Product Offered

Table 169. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. Abbott Main Business

Table 171. Abbott Latest Developments

List of Figures

Figure 1. Picture of Tenofovir Disoproxil Fumarate

Figure 2. Tenofovir Disoproxil Fumarate Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tenofovir Disoproxil Fumarate Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Tenofovir Disoproxil Fumarate Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tenofovir Disoproxil Fumarate Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 30 Pcs/Box

Figure 10. Product Picture of 10 Pcs/Box

Figure 11. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type in 2021

Figure 12. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2017-2022)

Figure 13. Tenofovir Disoproxil Fumarate Consumed in HIV-1 Infection

Figure 14. Global Tenofovir Disoproxil Fumarate Market: HIV-1 Infection (2017-2022) & (K Pcs)

Figure 15. Tenofovir Disoproxil Fumarate Consumed in Chronic Hepatitis

Figure 16. Global Tenofovir Disoproxil Fumarate Market: Chronic Hepatitis (2017-2022) & (K Pcs)

Figure 17. Tenofovir Disoproxil Fumarate Consumed in Other

Figure 18. Global Tenofovir Disoproxil Fumarate Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2017-2022)

Figure 20. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application in 2021

Figure 21. Tenofovir Disoproxil Fumarate Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Company in 2021

Figure 23. Global Tenofovir Disoproxil Fumarate Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Geographic Region in 2021

Figure 25. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2017-2022)

Figure 26. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Country/Region in 2021

Figure 27. Americas Tenofovir Disoproxil Fumarate Sales 2017-2022 (K Pcs)

Figure 28. Americas Tenofovir Disoproxil Fumarate Revenue 2017-2022 ($ Millions)

Figure 29. APAC Tenofovir Disoproxil Fumarate Sales 2017-2022 (K Pcs)

Figure 30. APAC Tenofovir Disoproxil Fumarate Revenue 2017-2022 ($ Millions)

Figure 31. Europe Tenofovir Disoproxil Fumarate Sales 2017-2022 (K Pcs)

Figure 32. Europe Tenofovir Disoproxil Fumarate Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Tenofovir Disoproxil Fumarate Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue 2017-2022 ($ Millions)

Figure 35. Americas Tenofovir Disoproxil Fumarate Sales Market Share by Country in 2021

Figure 36. Americas Tenofovir Disoproxil Fumarate Revenue Market Share by Country in 2021

Figure 37. United States Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Tenofovir Disoproxil Fumarate Sales Market Share by Region in 2021

Figure 42. APAC Tenofovir Disoproxil Fumarate Revenue Market Share by Regions in 2021

Figure 43. China Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Tenofovir Disoproxil Fumarate Sales Market Share by Country in 2021

Figure 50. Europe Tenofovir Disoproxil Fumarate Revenue Market Share by Country in 2021

Figure 51. Germany Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Tenofovir Disoproxil Fumarate Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Tenofovir Disoproxil Fumarate Revenue Market Share by Country in 2021

Figure 58. Egypt Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Tenofovir Disoproxil Fumarate Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Tenofovir Disoproxil Fumarate in 2021

Figure 64. Manufacturing Process Analysis of Tenofovir Disoproxil Fumarate

Figure 65. Industry Chain Structure of Tenofovir Disoproxil Fumarate

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390